Buy Palbociclib 125 mg Capsules | Oncology Supply – Gilla Pharma
Palbociclib 125 mg Capsules are an oral targeted therapy indicated for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer. Palbociclib is a selective CDK4/6 inhibitor that works by slowing cancer cell growth and improving outcomes when used in combination with endocrine therapy.
The most recognized branded version of Palbociclib is Ibrance.
Gilla Pharma supplies high-quality oncology medicines to Myanmar, Vietnam, Cambodia, Laos, and Indonesia, ensuring reliable sourcing and compliant distribution for hospitals, oncology centers, and licensed healthcare providers.
What is Palbociclib 125 mg Used For?
Palbociclib 125 mg is prescribed:
- In combination with letrozole or other aromatase inhibitors as initial endocrine-based therapy
- In combination with fulvestrant after progression on endocrine therapy
- For postmenopausal women and men with HR-positive, HER2-negative advanced breast cancer
It is not intended for use as monotherapy unless specifically advised by an oncologist.
How Palbociclib Works (Mechanism of Action)
Palbociclib inhibits Cyclin-Dependent Kinases 4 and 6 (CDK4/6) — proteins that regulate cell cycle progression.
By blocking these kinases, Palbociclib:
- Prevents cancer cells from dividing
- Slows tumor growth
- Enhances the effectiveness of hormone therapy
- Delays disease progression
This targeted mechanism makes it a cornerstone therapy in HR-positive metastatic breast cancer management.
Dosage & Administration
Recommended Dose: 125 mg once daily
Treatment Cycle: 21 days on treatment, followed by 7 days off (28-day cycle)
Administration: Take orally with food
Swallow capsule whole (do not crush or chew)
Dose adjustments may be required based on blood counts and tolerability.
Common Side Effects
Patients may experience:
- Neutropenia (low white blood cell count)
- Fatigue
- Nausea
- Diarrhea
- Hair thinning
- Stomatitis (mouth sores)
- Increased risk of infections
Routine blood monitoring is essential during treatment.
Important Safety Information
- Use only under oncologist supervision
- Not recommended during pregnancy
- Effective contraception required during treatment
- Monitor liver function and complete blood counts
- Inform your doctor about all current medications
Why Choose Gilla Pharma for Palbociclib Supply?
- Reliable oncology medicine supplier
- Competitive wholesale pricing
- Compliant export documentation
- Secure international shipping
- Serving Myanmar, Vietnam, Cambodia, Laos & Indonesia
- We work exclusively with licensed healthcare professionals, hospitals, and distributors.
Product Summary
| Attribute | Details |
|---|---|
| Generic Name | Palbociclib |
| Strength | 125 mg |
| Dosage Form | Oral Capsules |
| Drug Class | CDK4/6 Inhibitor |
| Indication | HR-positive, HER2-negative advanced breast cancer |
| Treatment Cycle | 21 days on / 7 days off |
Request a Quote for Palbociclib 125 mg
For bulk supply, pricing, or regulatory documentation, contact Gilla Pharma today.
📩 Email: info@gillapharma.com
📞 Phone: +91 95491 32929| +84 7645 21324
